Patient Navigation for Lung Screening at MGH Community Health Centers
To develop and implement a patient navigator (PN) program for lung screening and smoking cessation in community health center primary care practices. This program will be evaluated in a randomized controlled trial of primary care patients who currently smoke.
Checked against the public recordLast updated Jan 5, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Prevention
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Other: Patient Navigation; Other: Usual Care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. adult patients aged 55-77 years who are current cigarette smokers (according to an algorithm using electronic medical record data), and 2. receive care at one of the five Massachusetts General Hospital community health centers. Exclusion Criteria: 1. patients who have previously received a diagnosis of lung cancer, 2. have undergone a chest CT within 18 months before enrollment, 3. are subsequently identified as having died prior to the study intervention, 4. deemed by their primary care provider as not eligible for lung screening.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Massachusetts General HospitalBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 5, 2018. Always confirm current availability with the study team.